Tau Detection Assays for Specific Phosphorylated Tau Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for accurately assessing the risk of developing chronic traumatic encephalopathy (CTE) and monitoring its progression in individuals with traumatic brain injury, particularly from repeated blast exposures, due to non-specific symptoms and the difficulty in distinguishing between phosphorylated and non-phosphorylated tau proteins.
Innovation Solution
A method involving dual-capture assays using two capture reagents and one or more detection reagents to form complexes with tau proteins, followed by an extension process to quantify phosphorylated and total tau levels, allowing for precise measurement of p-tau and t-tau in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to assess neurodegeneration risk, then the assessment can be performed, but the accuracy and specificity are insufficient due to non-specific symptoms and inability to distinguish phosphorylated tau
Solution Approach 1:
The detection method is segmented into distinct functional components: capture reagents for immobilizing tau, detection reagents for specific recognition of phosphorylated tau, and extension reagents for signal amplification. This segmentation allows each component to be optimized for its specific function, improving overall measurement precision and reliability
Solution Approach 2:
Nucleic acid probes serve as intermediary molecules that bridge the capture reagents and detection systems. These probes specifically bind to phosphorylated tau and enable signal amplification through extension processes, thereby enhancing both the accuracy and specificity of tau detection
2Measurement precision
If dual-capture and detection reagents with nucleic acid probes are used, then sensitivity and specificity are improved, but the device complexity increases
Solution Approach 1:
Multiple detection functions are merged into a single integrated assay system. The capture reagents, detection reagents with nucleic acid probes, and extension processes are combined in one workflow, allowing simultaneous achievement of high sensitivity and specificity without requiring multiple separate complex devices
Solution Approach 2:
The detection reagents are designed with multi-functionality, incorporating both specific binding capabilities for phosphorylated tau and nucleic acid probe components for signal amplification. This universality reduces the need for separate specialized reagents, thereby managing complexity while maintaining high measurement precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a simple, sensitive, and specific assay with improved accuracy and dynamic range for detecting and quantifying tau proteins, enabling effective assessment of CTE risk and monitoring its progression.
Implementation Method 1
a first detection reagent that binds non-phosphorylated tau, wherein the first detection reagent comprises a first nucleic acid probe; and a second detection reagent that binds p-tau, wherein the second detection reagent comprises a second nucleic acid probe
Implementation Method 2
using an extension process that requires the first and second nucleic acid probes to be in proximity, extending the second nucleic acid probe to form an extended sequence comprising an anchoring region
Data Source
AI summary
The invention relates to methods and kits for assessing brain injury, e.g., traumatic brain injury resulting from blast exposure. The invention provides methods of quantifying the amount of phosphorylated tau or total tau in a biological sample. The invention further provides a method of determining the number of blast exposures experienced by a subject. Also provided herein are kits for detecting phosphorylated tau or total tau in a biological sample.